Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp. Dermatol Reports [Internet]. 2026 May 6 [cited 2026 Oct. 19];. Available from: https://journals.pagepress.net/dr/article/view/10366